TY - JOUR
T1 - Current Issues and Options for Hormonal Contraception in Adolescents and Young Adult Women with Sickle Cell Disease
T2 - An Update for Health Care Professionals
AU - De Sanctis, Vincenzo
AU - Soliman, Ashraf T.
AU - Daar, Shahina
AU - Canatan, Duran
AU - Di Maio, Salvatore
AU - Kattamis, Christos
N1 - Publisher Copyright:
© 2020 Limited Liability Company KlinMed Consulting. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Women with sickle cell disease (SCD) are of particular concern regarding the significantly increased risk of pregnancy-related morbidity, mortality, and adverse outcomes. They have limited knowledge of pregnancy and childbirth risks, as well as of the benefits and risks of contraceptives. Thus, there is an urgent need for appropriate information about reproductive family planning to reduce unintended pregnancy. Any decision regarding the use of contraceptives has to be based on the efficacy and risk/benefit ratio of the method used. Both the World Health Organization (WHO) and the Centers for Disease Control (CDC) have developed, published, and updated evidence-based guidelines for medical providers for the use of contraceptives in patients with specific medical chronic conditions. This article provides an overview of the present knowledge on the use of contraceptives in women with SCD. We believe that the collaboration between health care professionals (hematologists, obstetricians, endocrinologists, and primary care providers) can play a major role in identifying the safer contraceptive method to abolish the risks of unintended pregnancy and preserve the health status of patients with SCD.
AB - Women with sickle cell disease (SCD) are of particular concern regarding the significantly increased risk of pregnancy-related morbidity, mortality, and adverse outcomes. They have limited knowledge of pregnancy and childbirth risks, as well as of the benefits and risks of contraceptives. Thus, there is an urgent need for appropriate information about reproductive family planning to reduce unintended pregnancy. Any decision regarding the use of contraceptives has to be based on the efficacy and risk/benefit ratio of the method used. Both the World Health Organization (WHO) and the Centers for Disease Control (CDC) have developed, published, and updated evidence-based guidelines for medical providers for the use of contraceptives in patients with specific medical chronic conditions. This article provides an overview of the present knowledge on the use of contraceptives in women with SCD. We believe that the collaboration between health care professionals (hematologists, obstetricians, endocrinologists, and primary care providers) can play a major role in identifying the safer contraceptive method to abolish the risks of unintended pregnancy and preserve the health status of patients with SCD.
KW - Contraception
KW - Pregnancy
KW - Pregnancy
KW - Recommendations
KW - Sickle Cell Disease
KW - Sickle Cell Disease
UR - http://www.scopus.com/inward/record.url?scp=85087986425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087986425&partnerID=8YFLogxK
U2 - 10.4084/MJHID.2020.032
DO - 10.4084/MJHID.2020.032
M3 - Review article
C2 - 32395221
AN - SCOPUS:85087986425
SN - 2035-3006
VL - 12
JO - Mediterranean Journal of Hematology and Infectious Diseases
JF - Mediterranean Journal of Hematology and Infectious Diseases
IS - 1
M1 - e2020032
ER -